Mandibular hypoplasia, deafness, progeroid features and lipodystrophy (MDPL) syndrome in the context of inherited lipodystrophies
| Autor: | Ilenia Zara, Magdalena Zoledziewska, Chris Jones, Laura Crisponi, Josh Smith, Riccardo Berutti, Deborah A. Nickerson, Roberto Cusano, Serena Sanna, Manuela Oppo, Decio Cerimele, Maria A. Montesu, Francesco Cucca, Andrea Angius, M. Valentini, David S. Hanna, Rosanna Satta, Frederic Reinier, Francesca Cottoni |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Adult
Male medicine.medical_specialty Lipodystrophy POLD1 Endocrinology Diabetes and Metabolism Context (language use) Syndrome Deafness Biology medicine.disease Familial partial lipodystrophy Hypoplasia Pedigree Congenital generalized lipodystrophy Endocrinology Internal medicine medicine Humans Female Mandibular Diseases Exome sequencing Werner syndrome |
| Zdroj: | Metabolism. 64:1530-1540 |
| ISSN: | 0026-0495 |
| DOI: | 10.1016/j.metabol.2015.07.022 |
| Popis: | Background Lipodystrophies are a large heterogeneous group of genetic or acquired disorders characterized by generalized or partial fat loss, usually associated with metabolic complications such as diabetes mellitus, hypertriglyceridemia and hepatic steatosis. Many efforts have been made in the last years in identifying the genetic etiologies of several lipodystrophy forms, although some remain to be elucidated. Methods We report here the clinical description of a woman with a rare severe lipodystrophic and progeroid syndrome associated with hypertriglyceridemia and diabetes whose genetic bases have been clarified through whole-exome sequencing (WES) analysis. Results This article reports the 5th MDPL (Mandibular hypoplasia, deafness, progeroid features, and lipodystrophy syndrome) patient with the same de novo p.S605del mutation in POLD1. We provided further genetic evidence that this is a disease-causing mutation along with a plausible molecular mechanism responsible for this recurring event. Moreover we overviewed the current classification of the inherited forms of lipodystrophy, along with their underlying molecular basis. Conclusions Progress in the identification of lipodystrophy genes will help in better understanding the role of the pathways involved in the complex physiology of fat. This will lead to new targets towards develop innovative therapeutic strategies for treating the disorder and its metabolic complications, as well as more common forms of adipose tissue redistribution as observed in the metabolic syndrome and type 2 diabetes. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect